Prevalence (%) [95% CI] | Microhematuria | Faecal occult blood (FOB) | |||
---|---|---|---|---|---|
31.5 [27.5–35.5] | 16.2 [11.0–21.4] | ||||
Sample size | n = 520 | n = 191α | |||
Unadjusted odds ratio (95% CI) [P-value] | Adjusted odds ratio (95% CI) [P-value] | Unadjusted odds ratio (95% CI) [P-value] | Adjusted odds ratio (95% CI) [P-value] | ||
Urine-CCA testβ | Negative | 1 | 1 | 1 | 1 |
Positive | 2.0 (1.4–3.0) [< 0.01] | 1.2 (0.6–2.6) [0.61] | 12.9 (4.3–38.7) [< 0.01] | 9.2 (3.0–28.6) [< 0.01] | |
Ova-patent intestinal schistosomiasis (Kato-Katz) | Negative | 1 | 1 | 1 | 1 |
Positive | 2.2 (1.0–4.7) [0.06] | 3.0 (1.0–8.6) [0.04] | 11.4 (3.9–33.3) [< 0.01] | 6.7 (2.0–22.6) [< 0.01] | |
Ova-patent urogenital schistosomiasis (urine filtration) | Negative | 1 | 1 | 1 | 1 |
Positive | 42.1 (23.2–76.5) [< 0.01] | 47.9 (22.6–101.5) [< 0.01] | 1.6 (0.7–3.8) [0.25] | 1.5 (0.5–4.9) [0.49] | |
Praziquantel treatment in last 12 months | No | 1 | 1 | 1 | 1 |
Yes | 0.7 (0.5–1.1) [0.16] | 0.7 (0.3–1.8) [0.45] | 0.5 (0.2–1.3) [0.16] | 0.8 (0.3–2.3) [0.65] | |
Gender | Male | 1 | 1 | 1 | 1 |
Female | 1.0 (0.7–1.4) [0.85] | 0.9 (0.5–1.8) [0.82] | 1.1 (0.5–2.3) [1.00] | 1.0 (0.4–2.4) [0.97] | |
Age (years) | 6–10 | 1 | 1 | 1 | 1 |
11–15 | 0.9 (0.6–1.4) [0.71] | 1.2 (0.6–2.3) [0.63] | 1.1 (0.507–2.4) [0.81] | 0.9 (0.3–2.3) [0.78] |